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The biological significance of Archaea in the human gut microbiota is largely unclear. We recently
reported genomic and biochemical analyses of the Methanomassiliicoccales, a novel order of
methanogenic Archaea dwelling in soil and the animal digestive tract. We now show that these
Methanomassiliicoccales are present in published microbiome data sets from eight countries. They
are represented by five Operational Taxonomic Units present in at least four cohorts and
phylogenetically distributed into two clades. Genes for utilizing trimethylamine (TMA), a bacterial
precursor to an atherosclerogenic human metabolite, were present in four of the six novel
Methanomassiliicoccales genomes assembled from ELDERMET metagenomes. In addition to
increased microbiota TMA production capacity in long-term residential care subjects, abundance
of TMA-utilizing Methanomassiliicoccales correlated positively with bacterial gene count for TMA
production and negatively with fecal TMA concentrations. The two large Methanomassiliicoccales
clades have opposite correlations with host health status in the ELDERMET cohort and putative
distinct genomic signatures for gut adaptation.
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Introduction
The human microbiome is now recognized as an
environmental modifier of disease risk (Grice and
Segre, 2012). Definition of the catalog of taxa and
gene functions in multiple large-scale projects, with
a particular emphasis on the gut, has allowed the
identification of altered microbiota compositions or
functional states that correlate with disease states
(Qin et al., 2010; Human Microbiome Project
Consortium, 2012; Le Chatelier et al., 2013;
Forslund et al., 2015; Falony et al., 2016). Most
large-scale microbiome studies have focussed on the
Bacteria, with relatively little attention being paid to
the viral, micro-eukaryotic and archaeal compo-
nents. It is notable, however, that the domain
Archaea is the only domain of life that includes no
pathogenic members. Their association with human
health have been questioned for many years since
the pioneering study by the Levitt group (Bond et al.,
1971) and the isolation of the first two methanogen
species consistently found in the human microbiota,
Methanobrevibacter smithii (Miller et al., 1982) and
Methanosphaera stadtmanae (Miller and Wolin,
1985). These two taxa belong to the Methanobacter-
iales order. There is one clear case of health
association evident in the higher occurrence rate of
Methanobrevibacter oralis in periodontal diseases,
whereby this methanogen could promote the growth
of pathogenic bacteria by lowering the redox level
(Lepp et al., 2004). Independent of health condition,
another commonly reported trend is the increase of
methanogen occurrence and diversity among older
adults (Mihajlovski et al., 2010; Dridi et al., 2012a;
Fernandes et al., 2013; Polag et al., 2014). However,
beyond those two associations, few links between
methanogen occurrence/abundance and health con-
ditions have been consistently reported over multi-
ple studies. Several recent findings and mechanistic
hypotheses have offered new perspectives on poten-
tial implications of methanogens for human health
(as reviewed in Gaci et al., 2014; Bang and Schmitz,
2015; Horz, 2015; Lurie-Weinberger and Gophna,
2015). Among these, three studies have reported that
Msp. stadtmanae, but not Mbr. smithii, could have
an important pro-inflammatory effect in the
lung (Blais Lecours et al., 2011) and in the gut
(Bang et al., 2014; Blais Lecours et al., 2014).
Moreover, occurrence of Msp. stadtmanae is more
frequent in subjects with inflammatory bowel dis-
ease (Blais Lecours et al., 2014), raising questions
about its potential role in the development of
allergic and autoimmune diseases (Bang and
Schmitz, 2015).
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During the same time frame, our understanding of
the diversity of human-associated methanogens was
extended by the description of three novel methano-
gen species, Methanomassiliicoccus luminyensis
(Gorlas et al., 2012; Dridi et al., 2012b), ‘Candidatus
Methanomassiliicoccus intestinalis Mx1’ (Borrel
et al., 2013) and ‘CandidatusMethanomethylophilus
alvus Mx1201’ (Borrel et al., 2012), constituting the
first cultured and sequenced representatives of a
novel order of Archaea, the Methanomassiliicoc-
cales. The characterization of these methanogens led
us to propose that human-associated Archaea might
even have unexpected positive effects on health
(Brugère et al., 2014; Gaci et al., 2014). Specifically,
these species have the genetic potential to deplete a
deleterious compound, trimethylamine (TMA),
through methanogenesis based on the H2-dependent
reduction of methyl compounds (Borrel et al., 2014).
This predicted metabolic activity was subsequently
confirmed by biochemical characterization of Mmc.
luminyensis (Brugère et al., 2014). In the human
body, TMA is produced exclusively by the activity of
gut bacteria (Koeth et al., 2013). After diffusion into
the blood, TMA is oxidized by the liver enzyme
FMO3 monooxygenase into trimethylamine-N-oxide
(TMAO), a molecule increasingly recognized as an
important factor for the development of cardiovas-
cular disease (Wang et al., 2011; Zhu et al., 2016) and
chronic kidney diseases (Tang et al., 2015). Also, the
physiological deficiency of the liver FMO3 mono-
oxygenase prevents the oxidation of TMA to TMAO
and causes trimethylaminuria, a condition that
affects 0.5%–11% of people across distinct ethnic
populations (Mitchell et al., 1997; Mackay et al.,
2011). By removing TMA directly from its source,
naturally occurring Methanomassiliicoccales repre-
sentatives could help to prevent cardiovascular
disease, chronic kidney diseases or trimethylami-
nuria. Thus we proposed that human-associated
Methanomassiliicoccales strains could be used as
probiotics, namely, ‘Archaebiotics’, particularly for
mitigating trimethylaminuria (Brugère et al., 2014).
However, the functional diversity of human-
associated Methanomassiliicoccales is still poorly
understood and many aspects need further explora-
tion in order to clarify their role in TMA bioremedia-
tion (naturally occurring or deliberately instigated)
and other yet undefined connections with human
health.
In the present study, we identified the predomi-
nant Methanomassiliicoccales representatives asso-
ciated with the human gut microbiome based on a
meta-analysis of published data sets and novel data
from the ELDERMET cohort of older subjects (464
years of age) in Ireland (Claesson et al., 2011, 2012;
O’Toole and Jeffery, 2015). The capacity of predo-
minant Methanomassiliicoccales species to utilize
TMA was then assessed by analyzing six genomes
assembled de novo from ELDERMET metagenomics
data and by the biochemical characterization of
‘Ca. Mmp. alvus’. Additionally, we determined
Methanomassiliicoccales levels in ELDERMET gut
samples and compared them with fecal TMA
concentrations. Functional links between TMA-
producing bacteria and Methanomassiliicoccales
were further explored by evaluating the effect of
the redundancy and level of four distinct bacterial
TMA-producing pathways on Methanomassiliicoc-
cales distribution. Previous analyses of the ELDER-
MET cohort have focussed on diet–microbiota–
health interactions and reported an accelerated
health decline linked with diet modification and a
strong shift in the bacterial microbiota composition
after subjects entered long-term residential care
(Claesson et al., 2011, 2012; O’Toole and Jeffery,
2015). We investigated how Methanomassiliicoc-
cales distribution is affected by this important
lifestyle modification. Putative genomic signatures
accounting for differential abundance of these
Archaea were identified.
Experimental Procedures
ELDERMET cohort data
The subjects are Irish people aged 464 years. They
were recruited as previously described (Claesson
et al., 2011). Ethical approval was obtained from the
Cork Clinical Research Ethics Committee. Subjects
provided an informed consent. In case of cognitive
impairment, consent was given by the next-of-kin to
the subject. None of the subjects has an advanced
organic disease, alcohol abuse or participates to a
drug intervention. The average age of the 371
ELDERMET subjects is 78 (±8) years and range from
64 to 102 years. Frailty of the subjects was previously
assessed with Functional Independence Measure
index and Barthel Score (Jeffery et al., 2016).
Molecular methods and bioinformatics
DNA extraction and bacterial 16S rRNA amplicon
sequencing was previously performed on 732 stool
samples from the 371 ELDERMET subjects as
described in Jeffery et al., (2016). Shotgun sequen-
cing of the total fecal DNA of a subset of 190
ELDERMET samples was performed using the
Illumina HiSeq 2000 (Illumina Inc., San Diego, CA,
USA) to generate 100 bp paired-end read libraries
following the manufacturer’s instructions. Reads
were assembled de novo using IDBA_UD v1.1.1
(Peng et al., 2012).
Methanomassiliicoccales 16S rRNA sequences
from publically available cohorts/data sets were
obtained from NCBI, EMBL or were provided by
the authors of published studies and used to query
(with blastn) the ELDERMET metagenomes to iden-
tify Methanomassiliicoccales 16S rRNA within this
cohort. Operational Taxonomic Units (OTUs) were
defined using the USEARH suite of algorithms on
publically available and newly identified ELDER-
MET 16S rRNA gene sequences (Edgar, 2010).
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The cluster_fast script was implemented with the
length sorting option and a 97% identity cutoff.
Six ELDERMET samples having Methanomassilii-
coccales 16S rRNA genes on contigs 410 kb in their
associated metagenomes were resequenced in order
to improve the length and coverage of Methanomas-
siliicoccales sequences. Newly obtained reads were
pooled and assembled with reads from the first
sequencing round. Draft genomes were constructed
from six metagenomic samples with Methanomassi-
liicoccales contigs identified based on binning by
read coverage, guanine–cytosine content and tetra-
nucleotide frequency using Emergent Self-
Organizing Maps (Dick et al., 2009; Supplementary
Figure S1) and comparisons to publically available
reference genomes. Tetranucleotide frequency cal-
culations were performed on 5–10 kb fragments of
scaffolds45 kb. Completeness and contamination of
the draft genomes were estimated based on a
presence/absence analysis of 199 single-copy marker
genes shared by complete genomes belonging to the
Diaforarchaea, the super-class of Archaea containing
the Methanomassiliicoccales (Supplementary
Table S1). KEGG (Kyoto Encyclopedia of Genes and
Genomes) orthology (KO) annotation was carried out
with BlastKOALA (Kanehisa et al., 2016). The core,
variable and pan-genome were computed with SiLiX
(Miele et al., 2011), using the online Microscope
platform of Genoscope (http://www.genoscope.cns.
fr) with threshold cutoffs of 50% identity and 80%
alignment length. Genome annotation was per-
formed using the NCBI Prokaryotic Genome Annota-
tion Pipeline and results were manually curated.
Proteins containing the Flg_New (pfam09479) and
Sel1_repeat (pfam09479) domains were identified
with IMG/ER database (November 2015) against
13 871 draft and complete prokaryotic and eukar-
yotic genomes (Markowitz et al., 2012).
Quantification of the ‘Host-associated clade’
Methanomassiliicoccales and ‘Free-living clade’
Methanomassiliicoccales, as well as Mbr. smithii
and Msp. stadtmanae were performed by quantita-
tive PCR (qPCR) using newly designed primers
(Supplementary Table S2). The detection level and
specificity of these primers was evaluated based on
comparisons with metagenomic reads mapping to
the corresponding 16S rRNA genes as described in
Supplementary Experimental Procedures and
Supplementary Figure S2. For absolute quantifica-
tions, a standard was added to all qPCR. It was
prepared using a plasmid containing a cloned 16S
rRNA or mcrA amplicon, which was serially 10
times diluted from 108 to 102 copies per μl. Bacteria
were quantified using the F_Bact1369/R_Prok1492
primer set (Sokol et al., 2009) and were used to
determine relative abundance of the four quantified
archaeal lineages. Quantifications were performed
on 342 ELDERMET subjects. The potential associa-
tion of the four lineages of Archaea with the
four bacterial microbiota modules defined by
Jeffery et al. (2016), grouping OTUs as Core,
Diversity-Associated, Longstay-Associated and
Reduced Core, was determined by correlating their
abundance with the sum of logged abundances of
rarefied OTUs from each module for each subject.
The correlation test performed was Pearson’s pro-
duct moment correlation. Differences in prevalence
or relative abundance of methanogens (species or
clades) were determined by generalized linear
models of either the binomial (prevalence) or
quasibinomial (relative abundance) family, in order
to adjust for the age of the subjects. The stability of
carriage of the four archaeal lineages was evaluated
by quantifications performed on 107 stool samples
collected 3 months and/or 6 months after the first
sampling time. Four additional species specific
primer sets were designed to independently target
the 16S rRNA gene and the mcrA gene of ‘Ca. Mmc.
intestinalis’ and Mmc. luminyensis (Supplementary
Table S2).
Samples containing Methanomassiliicoccales
representatives that likely have the capacity to
deplete TMA were identified based on metagenomic
analysis and qPCR, as described in Supplementary
Experimental Procedures. Identification of bacterial
TMA production markers (cntA/yeaW, cutC, grdH,
torA) in the ELDERMET metagenomes is described
in Supplementary Experimental Procedures.
Measurement of fecal TMA levels
TMA concentrations were measured by proton
nuclear magnetic resonance spectroscopy in fecal
water samples from 189 subjects, corresponding to
the same samples used for molecular biology
(amplicon sequencing, shotgun sequencing, qPCR)
analysis. The measurements were carried out by The
Metabolomic Innovation Center (TMIC, Edmonton,
Canada). Sample preparation, nuclear magnetic
resonance spectroscopy and compound identifica-
tion are described in Supplementary Experimental
Procedures. The limit of detection was 1 μM and no
values were below this limit.
Characterization of ‘Ca. Mmp. alvus’ enrichment
culture
The enrichment culture of ‘Ca. Mmp. alvus’ corre-
sponds to the culture used for the sequencing of ‘Ca.
Mmp. alvus Mx1201’ (Borrel et al., 2012). Growth
experiments were performed in a modified DSMZ
medium 119 under a N2/H2/CO2 (55:35:10) gas
phase. Modifications consist of the addition of
5ml l−1 of trace element solution and vitamin
solution from the DSMZ medium 141 and replace-
ment of sludge fluid by rumen fluid. Methanol and
TMA (both Sigma-Aldrich, Munich, Germany) were
added at a final concentration of 20mM. Growth of
‘Ca. Mmp. alvus’ and bacteria in the presence of
TMA+H2, methanol+H2 or with H2 in the absence of
methyl compound was measured by qPCR with
primers used for quantifying the ‘Host-associated
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clade’ Methanomassiliicoccales ELDERMET cohort
(Supplementary Table S2). Methane and hydrogen
present in the headspace were measured with a gas
chromatograph after 5 days of incubation.
Results and Discussion
Five candidate species from the order
Methanomassiliicoccales were most frequently found
across 10 cohort data sets analyzed
To date, only two studies specifically investigated
Methanomassiliicoccales diversity and distribution
in multiple human subjects. Our previous study by
Mihajlovski et al., (2010) reported five different
Methanomassiliicoccales OTUs designated Mx-01
to Mx-05, while the study of Vanderhaeghen et al.
(2015) identified only one OTU that showed high
sequence similarity to Mx-02. Mx-01 and Mx-05
Methanomassiliicoccales have now been cultured
and correspond to ‘Ca. Mmc. intestinalis’ and ‘Ca.
Mmp. alvus’, respectively (Borrel et al., 2012, 2013).
In order to determine the prevalence and abundance
of Methanomassiliicoccales representatives in the
human microbiome, we made a census of Methano-
massiliicoccales sequences present in 10 studies on
the human gut microbiota (Mihajlovski et al., 2008;
Scanlan et al., 2008; Mihajlovski et al., 2010;
Hoffmann et al., 2013; Goodrich et al., 2014;
Nielsen et al., 2014; Clemente et al., 2015; Pozuelo
et al., 2015; Vanderhaeghen et al., 2015), extending
these data sets with 16S rRNA gene sequences
extracted from 190 previously unpublished shotgun
metagenome data sets from the ELDERMET cohort.
A total of nine Methanomassiliicoccales OTUs
(97% identity cutoff) were identified across this
combined survey of the human gut microbiome and
these likely represent distinct species. Among them,
five were detected in at least four cohorts from four
different countries and could be considered as the
Methanomassiliicoccales representatives most pre-
dominantly associated with the human gut micro-
biome (Table 1). The most widely distributed OTU,
found in 8 out of the 11 cohorts, clusters with ‘Ca.
Mmc. intestinalis’ and Mmc. luminyensis sequences.
However, in all cohorts analyzed, sequences of this
OTU were 100% identical to ‘Ca. Mmc. intestinalis’
or closer to this species than to Mmc. luminyensis.
This suggests that ‘Ca. Mmc. intestinalis’ is more
often associated with the human gut microbiome
thanMmc. luminyensis. One of the five predominant
OTUs has never been reported previously and we
now designate it as Mx-06 in concordance with our
previous nomenclature in Mihajlovski et al. (2010).
The three others correspond to ‘Ca. Mmp. alvus’ and
to the uncultured Mx-02 and Mx-03 sequences
identified by Mihajlovski et al. (2010). Almost all
the predominant human-associated Methanomassi-
liicoccales OTUs belong to a clade formed by
sequences found in the digestive tract of animals
(‘Host-associated clade’; Figure 1). The onlyTa
bl
e
1
M
et
h
an
om
as
si
li
ic
oc
ca
le
s
O
T
U
s
p
re
d
om
in
an
tl
y
as
so
ci
at
ed
w
it
h
th
e
h
u
m
an
gu
t
m
ic
ro
bi
om
e
ac
ro
ss
m
u
lt
ip
le
co
h
or
ts
R
ef
er
en
ce
M
et
h
od
T
ar
ge
t
ge
n
e
C
oh
or
t
or
ig
in
N
u
m
be
r
of
su
bj
ec
ts
A
ge
ra
n
ge
N
u
m
be
r
of
O
T
U
s
O
cc
u
rr
en
ce
of
O
T
U
s
fo
u
n
d
ac
ro
ss
4
4
st
u
d
ie
s
M
ih
aj
lo
vs
ki
et
al
.
(2
00
8)
P
C
R
cl
on
in
g
16
S
/m
cr
A
F
ra
n
ce
6
25
–
69
1
M
in
ta
/M
lu
m
S
ca
n
la
n
et
al
.
(2
00
8)
P
C
R
cl
on
in
g
m
cr
A
Ir
el
an
d
20
7
19
–
74
1
M
in
t/
M
lu
m
M
ih
aj
lo
vs
ki
et
al
.
(2
01
0)
P
C
R
cl
on
in
g
16
S
/m
cr
A
F
ra
n
ce
60
0–
90
5
M
in
t/
M
lu
m
,
M
al
vb
,
M
x-
02
,
M
x-
03
,
M
x-
04
D
ri
d
i
et
al
.
(2
01
2a
)
qP
C
R
16
S
F
ra
n
ce
50
0
0–
10
0
—
M
in
t/
M
lu
m
?c
H
of
fm
an
et
al
.
(2
01
3)
N
G
S
on
am
p
li
co
n
s
16
S
U
S
A
96
18
–
40
3
M
in
t/
M
lu
m
,
M
x-
06
N
ie
ls
en
et
al
.
(2
01
4)
M
et
ag
en
om
ic
—
D
en
m
ar
k/
S
p
ai
n
39
6
18
–
70
1
M
al
v
G
oo
d
ri
ch
et
al
.
(2
01
4)
N
G
S
on
am
p
li
co
n
s
16
S
U
K
97
7
23
–
86
5
M
in
t/
M
lu
m
,
M
x-
02
,
M
x-
03
,
M
x-
06
C
le
m
en
te
et
al
.
(2
01
5)
N
G
S
on
am
p
li
co
n
s
16
S
A
m
er
in
d
ia
n
12
7–
48
3
M
x-
02
,
M
x-
06
V
an
d
er
h
ae
gh
en
et
al
.
(2
01
5)
P
C
R
cl
on
in
g
16
S
S
w
it
ze
rl
an
d
44
8–
78
1
M
x-
02
P
oz
u
el
o
et
al
.
(2
01
5)
N
G
S
on
am
p
li
co
n
s
16
S
S
p
ai
n
17
9
18
–
86
5
M
in
t/
M
lu
m
,
M
al
v,
M
x-
06
T
h
is
st
u
d
y
M
et
ag
en
om
ic
—
Ir
el
an
d
19
0
64
–
10
2
5
M
in
t/
M
lu
m
,
M
al
v,
M
x-
02
,
M
x-
03
,
M
x-
06
A
bb
re
vi
at
io
n
s:
N
G
S
,n
ex
t-
ge
n
er
at
io
n
se
qu
en
ci
n
g;
O
T
U
,O
p
er
at
io
n
al
T
ax
on
om
ic
U
n
it
;q
P
C
R
,q
u
an
ti
ta
ti
ve
P
C
R
.F
or
th
e
‘C
a.
M
m
c.
in
te
st
in
al
is
’/
M
m
c.
lu
m
in
ye
n
si
s
O
T
U
,‘
M
in
t’
w
as
u
n
d
er
li
n
ed
w
h
en
th
e
se
qu
en
ce
s
w
er
e
id
en
ti
ca
l
or
cl
os
er
to
‘C
a.
M
m
c.
in
te
st
in
al
is
’
th
an
M
m
c.
lu
m
in
ye
n
si
s.
a
N
am
ed
M
x-
01
.
b
M
x-
05
in
th
is
ea
rl
y
st
u
d
y.
c
P
re
se
n
ce
of
M
m
c.
lu
m
in
ye
n
si
s
w
as
d
et
er
m
in
ed
w
it
h
p
ri
m
er
s
an
d
p
ro
be
h
av
in
g
on
ly
on
e
m
is
m
at
ch
w
it
h
‘C
a.
M
m
c.
in
te
st
in
al
is
’.
M
in
t,
‘C
a.
M
m
c.
in
te
st
in
al
is
’;
M
lu
m
,M
m
c.
lu
m
in
ye
n
si
s;
M
al
v,
‘C
a.
M
m
p
.
al
vu
s’
.
P
re
se
n
ce
of
‘C
a.
M
m
c.
in
te
st
in
al
is
’
in
S
ca
n
la
n
et
al
.(
20
08
)
an
d
M
ih
aj
lo
vs
ki
et
al
.
(2
01
0)
w
as
in
fe
rr
ed
by
id
en
ti
fi
ca
ti
on
of
m
cr
A
se
qu
en
ce
s
h
av
in
g
4
99
%
n
u
cl
eo
ti
d
e
id
en
ti
ty
w
it
h
th
e
m
cr
A
se
qu
en
ce
of
th
is
sp
ec
ie
s.
Trimethylamine-utilizing Archaea of the human gut
G Borrel et al
2062
The ISME Journal
exception is the ‘Ca. Mmc. intestinalis’/Mmc. lumi-
nyensis OTU, which belongs to a clade of sequences
that are mainly associated with soil and sediment
environment (‘Free-living clade’; Figure 1). We
previously suggested that this phylogenetic and
environmental distribution indicates at least two
independent adaptation events to the gut micro-
biome during Methanomassiliicoccales evolution, an
ancient one in the last common ancestor of the ‘Host-
associated clade’ and a more recent one for ‘Ca.
Mmc. intestinalis’ and for Mmc. luminyensis (Borrel
et al., 2014). Differential adaptations as well as
health and microbiota associations of the members
of these two clades are investigated below to
substantiate that hypothesis.
Within the 190 stool metagenome data sets from
the ELDERMET cohort, all Methanomassiliicoccales
sequences correspond to the five predominant
human gut Methanomassiliicoccales OTUs
(Figure 1). All other archaeal sequences from the
ELDERMET cohort were assigned to the Methano-
bacteriales, with 99–100% identity to Mbr. smithii.
No Msp. stadtmanae sequences were detected
among assembled genes of the ELDERMET metagen-
omes (but they were detected by qPCR that has a
lower detection limit in our current study; see
Figure 1 Maximum likelihood phylogenetic tree of the Methanomassiliicoccales showing the diversity of human-associated
Methanomassiliicoccales. Sequences in red are from human-associated Methanomassiliicoccales and sequences in bold are obtained in
this study; large arrows indicate draft genomes obtained in this study and small arrows indicate sequences corresponding to complete or
draft genomes obtained in previous studies. Underlined sequences correspond to cultured representatives. Sequences of human-
associated Methanobacteriales were used to root the tree. Mx-07 to Mx-09 sequences are not included due to too short sequences available
for correct assignment but are given in Supplementary Information. Bootstrapping using 200 iterations was performed, black-filled dots
indicate nodes with bootstrap supports 490%, gray-filled dot 470% and white-filled dot 450%.
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following sections), suggesting that this species
occurs at lower abundance than the five Methano-
massiliicoccales OTUs and Mbr. smithii in these
elderly subjects. Because this shotgun sequence data
are not subject to PCR biases, this finding indicates
that Methanobacteriales and Methanomassiliicoc-
cales are the two most abundant archaeal orders in
the ELDERMET cohort. The dominance of these two
orders is in line with our previous census of the
archaeal lineages detected across multiple cohorts
(Gaci et al., 2014). Among the predominant human-
associated Archaea currently known, only Methano-
massiliicoccales Mx-02, Mx-03 and Mx-06 still lack
genomic and physiological characterization.
The pan-genome of predominant human-associated
Methanomassiliicoccales
We successfully assembled six draft genome sequences
of Methanomassiliicoccales from ELDERMET shotgun
sequence data (Table 2, Figure 1, Supplementary
Figure S1). Each draft genome was obtained from a
single metagenome. Three draft genomes correspond
to the uncultured Methanomassiliicoccales Mx-02,
Mx-03 and Mx-06. The three others were closely
related to previously sequenced Methanomassiliicoc-
cales genomes. Two were very similar to ‘Ca. Mmc.
intestinalis Mx1’ and were named ‘Ca. Mmc. intesti-
nalis 138’ and ‘Ca. Mmc. intestinalis 183’. The sixth
assembled genome was related to ‘Ca. Mmp. alvus
Mx1201’ and was named ‘Ca. Mmp. alvus 271’. The
draft genomes of Mx-02, Mx-03, ‘Ca. Mmc. intestinalis
138’, ‘Ca. Mmc. intestinalis 183’ and ‘Ca. Mmp. alvus
271’ were estimated to be complete and not contami-
nated (Table 2). The draft genome of Mx-06 was
estimated to be 87% complete and was thus not used
for the pan-genome analysis.
The pan-genome of the five new Methanomassilii-
coccales draft genomes analyzed in combination with
the ‘Ca. Mmp. alvus Mx1201’, ‘Ca. Mmc. intestinalis
Mx1’ andMmc. luminyensis genomes was predicted to
contain 7119 different gene families. Among these, 457
were shared by all 8 genomes, 1976 were shared by
2–7 genomes and 4686 were unique to 1 genome
(Figure 2a). The Mmc. luminyensis genome revealed
the highest proportion of unique genes (62%). Inter-
estingly, while ‘Ca. Mmp. alvus Mx1201’ and ‘Ca.
Mmp. alvus 271’ were phylogenetically close
(Figure 1), they harbored a relatively high proportion
of unique gene families (around 30% of their genome),
which suggests recent gene losses and acquisitions.
This highlights the potential importance and scale of
genome plasticity in Methanomassiliicoccales in the
gut. The variability of the number of genes with a
defined KEGG function is much lower (Supplementary
Figure S3). These KO annotated genes mainly corre-
spond to core metabolism. Rarefaction analysis on all
genes revealed that the rate of discovery of new gene
families is far from reaching a plateau based on the
eigth genomes available, which is not the case for the
KO annotated genes (Figure 2b). Thus a large
proportion of the genes that are unique or variably
present had only a general predicted function or an
unknown function. Completing the current genomic
data on the most common archaeal species found in
the human gut microbiota (Fricke et al., 2006; Samuel
et al., 2007; Hansen et al., 2011; Borrel et al., 2012,
2013), those genomes are useful to better understand
the biology of Archaea in the human gut. We next
investigated them to predict their TMA-utilizing
capacity and the gut adaptations of these Archaea.
Variation in TMA utilization potential in human gut
Methanomassiliicoccales
The five Methanomassiliicoccales representatives
with an estimated complete genome are very likely
to be methanogens as they harbored genes coding for
the methyl coenzyme M reductase complex as well
as the 17 other marker genes that are universal and
unique to methanogens (Borrel et al., 2014)
(Supplementary Table S3). The same assumptions
can be made for Mx-06, which was only missing 1 of
the 20 methanogenesis marker genes. In line with
previously characterized Methanomassiliicoccales
genomes, the six novel genomes lacked the genes
for reduction of CO2 by H2 or methyl group
oxidation, and they contained homologs of mtaA/
mtbA involved in methylated substrate utilization.
This genomic composition indicated that they likely
operate a methanogenesis based on the reduction of
methyl compound with H2, a characteristic shared by
all Methanomassiliicoccales so far analyzed. Pre-
sence of the genes involved in the utilization of
specific methyl compounds (methanol, metha-
nethiol, mono-, di- and TMA) as substrates for
methanogenesis was variable among the six newly
assembled genomes (Supplementary Table S3). The
genes for TMA utilization (mttBC) were found in the
genomes of ‘Ca. Mmp. alvus 271’, Mx-06, ‘Ca. Mmc.
intestinalis 138’ and ‘Ca. Mmc. intestinalis 183’.
Moreover, there was a congruent occurrence of the
16S rRNA and mttB genes of these three Methano-
massiliicoccales across ELDERMET metagenomes
and a strong correlation between the read counts of
the ‘Ca.Mmc. intestinalis’ 16S rRNA and mttB genes
(Pearson linear correlation: r2 = 0.74; P=10− 54). This
indicates that the different strains of these three
Methanomassiliicoccales consistently share the pre-
dicted capacity to deplete TMA. In contrast, this
capacity might be less regularly shared by other
predominant human gut Methanomassiliicoccales.
Indeed, Mx-03 mttB gene is split into two genes
coding for N- and C-terminal parts of the canonical
mttB gene (Supplementary Figure S4), and among
the four metagenomes where Mx-03 genome is
enriched, no read was mapped on Mx-03 mttB.
Regarding Mx-02, no mttB homolog was found in its
draft genome and within the three metagenomes
enriched in this methanogen. Supporting this lack in
Mx-02, the genes encoding pyrrolysine synthesis and
use (pylSBCD), an unusual amino acid conserved in
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the catalytic site of all characterized MttB proteins,
were not detected in the Mx-02 genome or respective
metagenomes. Interestingly, a similar absence of the
genes for methylated compound utilization as well
as pylSBCD genes was also observed in the Metha-
nomassiliicoccales RumEn M2, and for the moment,
the electron acceptors of these methanogens remain
unknown (Söllinger et al., 2016). The capacity to
deplete TMA is thus potentially not shared by all the
Methanomassiliicoccales that are commonly present
in the human microbiota.
Intestinal Methanomassiliicoccales prevalence/
abundance correlated with microbiota potential for
modulating TMA
We hypothesized that the occurrence of
Methanomassiliicoccales representatives with pre-
dicted ability to utilize TMA for growth (‘mttB
Methanomassiliicoccales’) would be influenced by
the TMA production potential of the gut microbiota.
Several pathways converting distinct dietary com-
pounds into TMA have been characterized and
found in many gut bacteria through genomic ana-
lyses (Falony et al., 2015; summarized in Figure 3a).
However, the genes encoding these pathways could
be variably present between strains of the same
species or genera, as recently exemplified for choline
conversion to TMA (Martínez-del Campo et al.,
2015). For this reason, we did not assess TMA
production potential on the basis of 16S rRNA gene
composition but based on functional markers
responsible for the final step of TMA production
within the four pathways (Figure 3a). Those proteins
are encoded by torA for TMAO conversion (Méjean
et al., 1994), cutC for choline conversion (Craciun
and Balskus, 2012), grdH for betaine conversion
(Meyer et al., 1995; Wagner et al., 1999) and cntA/
yeaW for L-carnitine conversion (Koeth et al., 2014;
Zhu et al., 2014). At the threshold of detection
allowed by the sequencing coverage of the current
study, marker genes were not detected in every
subject but in 70.8% of the subjects for grdH, 67.7%
for torA, 52.1% for cutC and 34.9% for cntA
(Figure 3b). Affiliation of those functional markers
and mapping of metagenomic reads on gene
sequences (including complete marker genes from
HMP genomes) revealed that only a few genera of
TMA producers were widely distributed among
ELDERMET subjects (Figure 3b, Supplementary
Table S4). Among these, Escherichia coli strains
could be important players in TMA production,
being variably involved in TMA production from
choline, L-carnitine and TMAO (Figure 3b). Clostri-
dium spp., potentially converting choline and
betaine to TMA, are phylogenetically diverse and
partially comprise uncharacterized species (or not
yet sequenced) but collectively could represent
important agents of TMA production in the human
gut (Figure 3b, Supplementary Table S4). Dorea
formicigenerans with a potential for conversion of
betaine to TMA is widely distributed among subjects
but never occurs at high relative abundance.
Samples containing ‘mttB Methanomassiliicoc-
cales’ were identified by a combination of qPCR
and metagenomic analyses as described in
Supplementary Experimental Procedures. Subjects
with a higher number of different TMA production
pathways encoded by their gut microbiota are more
likely to harbor Methanomassiliicoccales represen-
tatives that are able to use TMA as substrate. Indeed,
‘mttBMethanomassiliicoccales’ were detected in 6%
of the ELDERMET subjects with no TMA production
pathway detected in their gut microbiota and this
proportion progressively increased to 36% among
the subjects carrying a microbiota able to produce
TMA from four different precursors (Figure 3c).
More diversified TMA production pathways in a
single subject could allow the conversion of a larger
number of different food ingredients into TMA.
Figure 2 Pan-genome of human-associated Methanomassiliicoccales. (a) Core, variable and unique gene families in the pan-genome of
the human-associated Methanomassiliicoccales. Between brackets, the number of unique gene families and the percentage they represent
within each genome. The number of unique genes and its percentage are also given for the pan-genome of ‘Ca. Mmc. intestinalis’ as the
three genomes of this species are very close. Mint, ‘Ca. Mmc. intestinalis’; Malv, ‘Ca. Mmp. alvus’; Mlum, Mmc. luminyensis.
(b) Rarefaction analysis of gene family discovery in the pan-genome of human-associated Methanomassiliicoccales, determined on the
basis of identity percentage (dark green) and KO annotation (light green).
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A more regular production of this molecule might
help Methanomassiliicoccales to colonize and
persist in the microbiota. The influence of TMA-
producing bacteria in the presence of Methanomas-
siliicoccales is also suggested by a higher abundance
of TMA production pathways, and more specifically
those for carnitine (cntA) and choline (cutC) conver-
sion, in subjects with ‘mttB Methanomassiliicoc-
cales’ than without Methanomassiliicoccales
(Supplementary Figure S5). In addition to pathway
redundancy, a higher TMA production capacity of
the microbiota would thus help the Methanomassi-
liicoccales to develop in the human gut.
The predicted ability of human-associated Metha-
nomassiliicoccales to deplete TMA in the gut was
supported by comparison of experimentally deter-
mined fecal TMA concentrations in subjects harbor-
ing ‘mttB Methanomassiliicoccales’, ‘mttB lacking
Methanomassiliicoccales’ and subjects not carrying
Methanomassiliicoccales (Figure 3d). Lower TMA
concentrations were found in fecal samples of
subjects carrying ‘mttB Methanomassiliicoccales’
than in subjects without Methanomassiliicoccales.
The difference in fecal TMA concentrations between
subjects carrying ‘mttB Methanomassiliicoccales’
and subjects without Methanomassiliicoccales was
more significant when the abundance of ‘mttB
Methanomassiliicoccales’ was 4108 cells per gram
of stool than below (Figure 3d). Moreover, no
significant difference in fecal TMA concentration
was found between subjects carrying ‘mttB lacking
Methanomassiliicoccales’ and subject without
Methanomassiliicoccales (Figure 3d). Those results
parallel the negative correlation between Methano-
massiliicoccales abundance and urinary TMAO level
recently reported in a study of rumen communities
in lambs (Morgavi et al., 2015). In the current study,
while the presence of ‘mttB Methanomassiliicoc-
cales’ was associated with lower fecal TMA concen-
trations, an increased number of different TMA
production pathways was not significantly asso-
ciated with higher fecal TMA concentrations. This
could be due to variable level of expression of those
pathways depending on diet and potentially through
Figure 3 Microbial metabolisms modulating TMA concentrations in the human gut microbiome. (a) Schematic representation of the
pathways and associated marker genes modulating TMA concentrations in the gut microbiome and health output related to high TMA
productions. (b) Composition and carriage (%) of the potential TMA producers in the ELDERMET cohort. ‘Total’ corresponds to the
percentage of carriage of each marker gene among the subjects, regardless of the affiliation of the marker. (c) Percentage of carriage of
Methanomassiliicoccales representatives in subgroups of subjects having no TMA production pathway or one to four different TMA
production pathways detected in their microbiota. (d) Concentrations of fecal TMA (logged) among subjects without or with
Methanomassiliicoccales detected at different concentrations. No Mmass, no Methanomassiliicoccales detected; Mmass without mttB,
Methanomassiliicoccales potentially lacking the capacity to deplete TMA; mttB Mmass o108 and mttB Mmass 4108, Methanomassi-
liicoccales potentially depleting TMA having a concentration lower and higher than 108 cell per g stool, respectively. Significant
differences between groups are determined with Mann–Whitney test, *Po0.05, **Po0.001.
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leveling of high TMA values by its assimilation. In
situ depletion of TMA by Methanomassiliicoccales
representatives awaits experimental confirmation by
following blood TMAO concentration in an animal
model with defined diet and microbiota composi-
tion. These biomanipulations will require isolated
strains of the ‘mttB Methanomassiliicoccales’ pre-
dominantly found in the human microbiota, that is,
‘Ca. Mmp. alvus’, ‘Ca. Mmc. intestinalis’ or Mx-06.
Using an enrichment culture of ‘Ca. Mmp. alvus’
(Borrel et al., 2012), we confirmed the capacity of
this species to use TMA as a substrate by growth and
metabolite analysis (Supplementary Figure S6), mak-
ing it promising for future experiments on controlled
gut microbiota systems for TMA production/deple-
tion. This in vivo validation of genome annotation
further supports the notion that the predominant
‘mttB Methanomassiliicoccales’ could deplete TMA
within the human gut. Beyond the interesting
potential for the removal of deleterious methylated
compounds by Methanomassiliicoccales in the
human gut, it is important to better understand the
general biology and ecology of these methanogens in
the human gut and their overall interaction with the
bacterial microbiome.
Representatives of the two main
Methanomassiliicoccales clades have different
interactions with the gut microbiome and clinical
metadata
Subjects of the ELDERMET cohort are living in the
community or in residential care (either long term or
rehabilitation). Previous studies on this cohort have
revealed a progressive shift in the gut microbiota
composition of subjects entering long-term residen-
tial care (‘longstay subjects’) (Claesson et al., 2012;
O’Toole and Jeffery, 2015; Jeffery et al., 2016).
Detailed analysis of these changes has shown a
gradual loss of health-associated bacteria (gathered
under the Diversity-Associated module) and their
replacement by bacteria (Longstay-Associated mod-
ule) associated with increased frailty (Jeffery et al.,
2016). This recent analysis showed that frailty and
frailty-related microbiota alterations may occur
independently of age and residence location
(Jeffery et al., 2016). This alteration of the bacterial
microbiota is likely driven by diet and could
contribute to accelerated age-related health decline
(Claesson et al., 2012). We now report that the
composition of human gut Archaea, albeit a much
less diverse than bacteria, is also gradually changing
after the subjects enter residential care. (For simpli-
city, one intermediate residence location, day hospi-
tal, was omitted). This was investigated by using
qPCR to determine the prevalence of members of the
two main clades of Methanomassiliicoccales, the
‘Host-associated clade’ and the ‘Free-living clade’
(Figure 1), as well as Mbr. smithii and Msp.
stadtmanae. Three hundred and forty-two of these
samples had been collected at one time point (T0)
and 107 subjects sampled at one or two additional
time points separated by 3 months (T3 and T6).
Of the two Methanobacteriales species targeted,
only Mbr. smithii carriage rates interacted with time
spent in residential care (Figure 4a). Being present in
Figure 4 Prevalence and relative abundance of methanogens among elderly subjects living in community and according to the time spent
in residential care. Prevalence and relative abundance are presented for Methanobrevibacter smithii (a and b), Methanosphaera
stadtmanae (c and d), ‘Free-living clade’ Methanomassiliicoccales (e and f) and the ‘Host-associated clade’ Methanomassiliicoccales
(g and h). In panels (a), (c), (e) and (g), the dark blue bars represent prevalence among subjects at T0, while the clear blue bars take into
account subjects positive for at least one time point. For prevalence, Community (Com), n=125; Residential care 0–2 months (mth), n=61;
2–12 months, n=47;41 year, n=51. Statistical analysis and representation of the relative abundance of methanogens were carried out on
subjects with a positive detection of methanogens. *Po0.05, **Po0.01, ***Po0.001. Day hospital category is not presented for clarity but
is never different from Community.
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almost 70% of community-dwelling subjects, it
became nearly ubiquitous (94%) among residents
of 41 year and occurred at a higher relative
abundance than in community-dwelling subjects
(Figure 4b). Accordingly, Mbr. smithii positively
correlates with the Longstay-Associated module of
intestinal bacterial taxa (ρ=0.46; 10− 21). Despite this
association, Mbr. smithii has been previously
reported as a common component of the human
gut microbiota without particular distribution
according to health status (Scanlan et al., 2008;
Blais Lecours et al., 2014). Moreover, Mbr. smithii
has been reported to have a low inflammatory
potential (Bang and Schmitz, 2015), suggesting that
it is not directly contributing to increased inflamma-
tion associated with health decline among longstay
subjects (Claesson et al., 2012). The carriage rate and
abundance of Msp. stadtmanae was not significantly
different between community and residential care
dwellers (Figures 4c and d). This suggests that, in the
present case, Msp. stadtmanae is not associated with
increased inflammation levels of longstay subjects
(Claesson et al., 2012) and contrasts with the
previously suggested link between this methanogen
species and inflammation (Blais Lecours et al.,
2014).
In comparison to Methanobacteriales, more sig-
nificant prevalence differences were noted for the
Methanomassiliicoccales. Indeed, the carriage rate of
‘Free-living clade’ Methanomassiliicoccales was low
among community-dwelling subjects (4%) but pro-
gressively increased with time spent in residential
care to 55% among subjects being resident for longer
than a year (Figure 4e). Additionally, six longstay
subjects with no ‘Free-living clade’ Methanomassi-
liicoccales detected at T0 became positive for these
methanogens at either T6 or T3+T6 and were thus
potentially newly colonized during this 6-month
period. Taking into account those subjects, the
maximum prevalence of this clade could reach up
to 70% (Figure 4e). Furthermore, this higher pre-
valence was coupled with a410-fold increase in the
average relative abundance of ‘Free-living clade’
Methanomassiliicoccales after 2 months living in
residential care (Figure 4f), at which they stabilized
(Supplementary Figures S7A and B). In addition,
subjects harboring ‘Free-living clade’ had a higher
frailty level, when considering all subjects or only
residential care subjects (Supplementary Figure S8).
This prompted us to identify which members of this
clade are associated with this strong trend. Detailed
investigation using species-specific primers and
metagenomic analysis revealed that 90% of the
subjects positive for this clade were carrying ‘Ca.
Mmc. intestinalis’, whereas only 5% carried Mmc.
luminyensis. This supports our analysis of other
cohorts that suggests a generally higher proportion of
‘Ca. Mmc. intestinalis’ (Table 1). The frequency of
carriage of the ‘Host-associated clade’ Methanomas-
siliicoccales followed an opposite trend as they
gradually disappeared with time spent in residential
care (Figure 4g). This clade is more often present
among subjects in better health condition according
to frailty indices (Supplementary Figure S8). Despite
the progressive shift with time spent in residential
care, carriage and relative abundance of Methano-
massiliicoccales representatives was mostly stable
over a 6-month period (Supplementary Figure S7C).
The occurrence of the two clades tended to increase
with the age of the subjects but only among
community-dwellers for the ‘Host-associated clade’
and only among residential care subjects for the
‘Free-living clade’ (Supplementary Figure S9). More-
over, for the same age range, ‘Host-associated clade’
tended to be higher among community and residen-
tial care dwellers and inversely for ‘Ca. Mmc.
intestinalis’ (Supplementary Figure S9). In agree-
ment with the opposite distribution of the two
clades, the ‘Free-living clade’ Methanomassiliicoc-
cales was positively correlated with the Longstay-
Associated module (ρ=0.39; Po10− 14) while the
‘Host-associated clade’ was positively correlated to
the Diversity-Associated module (ρ=0.21; Po0.001).
Two questions arise from these contrasting dis-
tributions and module associations among Methano-
massiliicoccales. Is ‘Ca. Mmc. intestinalis’ a
deleterious invader while ‘Host-associated clade’
representatives are normal members of the human
gut microbiome? What are the factors leading to the
increased colonization of one and the loss of the
other among longstay subjects? A part of the answer
to these two questions may lie in the relationships
between Methanomassiliicoccales and TMA-
producing bacteria. Indeed, the prevalence of the
different TMA-producing pathways and their redun-
dancy increased with the time subjects spent in
residential care (Supplementary Figure S10), poten-
tially raising the level of plasma TMAO and the
development of associated cardiac and kidney
diseases. The greater level of ‘Ca. Mmc. intestinalis’
among longstay subjects could reduce the adverse
effect of this molecule on health, and in this way,
‘Ca. Mmc. intestinalis’ could be seen more as a
beneficial microorganism than a pathobiont. How-
ever, the immunogenic potential of this methanogen
has not yet been evaluated and should not be
neglected when considering its overall impact on
health. Although the potentially higher availability
of TMA could be a factor promoting the colonization
of ‘Ca.Mmc. intestinalis’, it does not explain why the
TMA using representatives of the ‘Host-associated
clade’ (‘Ca. Mmp. alvus’ and Mx-06) are not favored
but instead tend to be lost. Despite multiple attempts
to isolate members of the ‘Host-associated clade’,
including those from the human gut, no pure culture
of these Archaea has been obtained to date (Borrel
et al., 2012; Paul et al., 2012; Borrel et al., 2013; Iino
et al., 2013; Jin et al., 2014; Lang et al., 2015;
Söllinger et al., 2016). From this observation, it has
been previously suggested that members of this clade
could be dependent on unrecognized metabolite(s)
produced by co-occurring bacteria (Lang et al.,
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2015). This aspect will need to be further studied to
determine whether members of the ‘Host-associated
clade’ present in the human gut could be dependent
on some specific bacteria for such metabolites, and
whether those bacteria make part of the Diversity-
Associated module that tend to be lost among
residential care subjects (Jeffery et al., 2016).
As previously mentioned, specialization to the gut
microbiome could have occurred several times
during the evolution of the Methanomassiliicoccales
(Figure 1) (Borrel et al., 2014). In an evolutionary
context, it is interesting to observe that the Metha-
nomassiliicoccales representatives that potentially
co-evolved with the host for a longer evolutionary
period (those of the ‘Host-associated clade’) were
preferentially found in community-dwelling subjects
having a health-associated microbiota, while ‘Ca.
Mmc. intestinalis’, which adapted more recently to
this environment, became more prevalent with the
progressive alteration of the gut microbiota composi-
tion among residential care subjects. Four of the six
subjects newly colonized by ‘Ca. Mmc. intestinalis’
during the 6 months monitoring had an unstable
microbiota as defined by our previous analyses
(Jeffery et al., 2016) and one was taking antibiotics.
This suggests that microbiota instability could be one
of the factors that contribute to helping ‘Ca. Mmc.
intestinalis’ to colonize the gut among longstay
subjects. High prevalence of ‘Host-associated clade’
has been observed in several cohorts of healthy
subjects, such as an Amerindian cohort (Clemente
et al., 2015) in which data we found Mx-06 to be
present among 80% of the subjects, in a Swiss cohort
where Mx-02 was detected in 50% of the subjects
(Vanderhaeghen et al., 2015) and in a French cohort
of older adults (Mihajlovski et al., 2010) where
members of this clade were detected among 40% of
the subjects. A high prevalence of ‘Ca. Mmc.
intestinalis’ in a cohort of healthy subjects has never
been observed to date.
Genomic signatures suggesting different archaeal
strategies to colonize and persist in the gut microbiome
Previously sequenced and de novo assembled gen-
omes of Methanomassiliicoccales were screened for
traits that might account for the different distribution
of the two clades and potentially explain why ‘Ca.
Mmc. intestinalis’ is more commonly detected than
Mmc. luminyensis in the human gut microbiome.
Sequences encompassing two conserved domains,
Sel1_repeat (pfam08238) and Flg_new (pfam09479,
also called Listeria-Bacteroides repeats or B-repeats),
were highly enriched in several Methanomassilii-
coccales genomes. Comparison to all genomes from
the IMG/ER database revealed that the three ‘Ca.
Mmc. intestinalis’ genomes were among those with
the highest number of genes coding for Flg_new-
containing proteins while the two ‘Ca. Mmp. alvus’
and Mx-03 were among genomes with the highest
number of genes coding for Sel1_repeat-containing
proteins (Figure 5). Interestingly, Flg_new proteins
are absent from all other Archaea (with the exception
of two Archaea, Halosimplex carlsbadense and
Methanolobus psychrophilus that have one Flg_new
gene each). Our investigation of the lifestyle of the
bacteria with high number of genes coding for
Flg_new and Sel1_repeat proteins revealed that most
of them have been isolated from various animal hosts
and body sites (Supplementary Table S5), which is
in line with previous functional characterizations
and hypotheses on the role of these repeats in host–
microbe interactions (Mittl and Schneider-Brachert,
2007; Ebbes et al., 2011). The Flg_new domain was
characterized in the internalin InlB of Listeria
monocytogenes, a protein required for host cell
invasion, but this domain is also found in many
other membrane-bound proteins with no given
function (Ebbes et al., 2011). This domain have
structural similarities with β-grasp fold and mucin-
binding domains (Ebbes et al., 2011). Most of the
Methanomassiliicoccales Flg_new repeat proteins
Figure 5 Occurrence of genes encoding for Flg_new and Sel1_repeat domains in Methanomassiliicoccales and other genomes from the
three domains of life. Flg_new domains (a) and Sel1 repeat domains (b). Genomes are ordered from the highest occurrence to the lowest
occurrence of the genes coding those domains.
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have a transmembrane domain at either one or both
terminuses and are thus predicted to be almost
entirely outside of the cell (Supplementary Table
S6). These proteins were very variable in length
(ranging from 174 to 5834 amino acids) and in
number of Flg_new domains (ranging from 1 to 25)
and could have different accessory domains that are
redundant across the Methanomassiliicoccales gen-
omes (Supplementary Table S6). This is reminiscent
of the asn/thr-rich and adhesin-like proteins that are
also associated with the membrane, variable in
length and in number of repeat domains and
encoded by a high number of genes in Msp.
stadtmanae and Mbr. smithii, respectively (Fricke
et al., 2006; Samuel et al., 2007; Hansen et al., 2011).
The high heterogeneity and cell surface location of
Flg_new proteins suggest that they could be rapidly
evolving proteins that underwent repeated recombi-
nation events and duplications in order to interact
with a wider range of sites in the gut microbiome, as
previously suggested for the asn/thr-rich large
protein of Msp. stadtmanae (Fricke et al., 2006)
and the adhesin-like proteins of Mbr. smithii
(Samuel et al., 2007; Hansen et al., 2011). The
Sel1_repeat domain is an eukaryotic-like domain
found in proteins that regulate cell processes and
that are involved in interactions between bacteria
and eukaryotes (Mittl and Schneider-Brachert, 2007).
It has been previously reported that a high level of
eukaryotic-like proteins is a characteristic feature of
bacteria that have a long history of co-evolution with
eukaryotic hosts (Cazalet et al., 2004; Hentschel
et al., 2012). Interestingly, genes coding for Sel1_re-
peat proteins tended to be more abundant in
genomes of the ‘Host-associated clade’ Methanomas-
siliicoccales while genes coding for Flg_new pro-
teins occurred more frequently in ‘Ca. Mmc.
intestinalis’ genomes (Figure 5). Biochemical char-
acterization of these proteins will help to determine
whether they could account for different coloniza-
tion strategies between members of the ‘Host-
associated clade’ and ‘Ca. Mmc. intestinalis’. Mmc.
luminyensis was distinguished from all other
human-associated Methanomassiliicoccales repre-
sentatives by having only one gene coding for a
Sel1_repeat protein and none for a Flg_new protein
(Figure 5). The lack of a Flg_new protein in Mmc.
luminyensis is particularly striking considering that
the closely related ‘Ca. Mmc. intestinalis’ have up to
38 genes coding for these proteins. It could thus be
wondered whether this distinctive gene composition
in Mmc. luminyensis could participate to the low
prevalence of this species in human cohorts com-
pared with other Methanomassiliicoccales represen-
tatives (Table 1). We previously suggested that Mmc.
luminyensis could have a wider environmental
distribution than the human gut, harboring genomic
adaptations to thrive in soils such as an number of
important genes for oxidative stress resistance or
diazotrophy (Borrel et al., 2014). To this can also be
added the high-affinity K+ transport system (Kdp),
which was proposed as an adaptation to low K+
concentration in oligotrophic peat lands (Bräuer
et al., 2015). The other human gut-associated
Methanomassiliicoccales have a lower number of
genes for oxidative stress-resistance proteins and
none of the other genes reflecting adaptation to soils
present in Mmc. luminyensis, highlighting their
stronger specialization to gut microbiome member-
ship. Additionally, Mmc. luminyensis harbors genes
for mercury methylation (hgcAB) whose activity was
experimentally validated (Podar et al., 2015). These
genes were widely detected in anaerobic environ-
ments but never in the mammalian gut (Podar et al.,
2015), suggesting that they were not retained during
the evolution of species composing the commensal
microbiota due to the high toxicity of methylated
mercury for the host. Their presence in the Mmc.
luminyensis genome supports that this methanogen
is not a common gut commensal. The hgcAB genes
are not present in any of the six new draft genomes
reported in the current study and so mercury
methylation by these methanogens is not a consid-
eration for their role in health or disease.
Conclusion
This study highlights that human intestinal Archaea
should not be investigated as a uniform group when
exploring their potential relationships with health,
in line with previous reports of uneven immuno-
genic potential of human-associated Methanobacter-
iales species (Blais Lecours et al., 2014; Bang and
Schmitz, 2015). Our data provide evidence that some
archaeal species among the Methanomassiliicoccales
could reduce the adverse effect of TMA through their
specific activity and higher occurrence among sub-
jects with high TMA production potential. Our
results also indicate that the archaeal component of
the gut microbiome is clearly affected after the
subjects of this cohort enter residential care. As
previously reported for bacteria, this alteration could
be related to the significant physiological and
lifestyle changes that are features of long-term
residential care (Claesson et al., 2011, 2012;
O’Toole and Jeffery, 2015). The intriguing high
prevalence of ‘Ca. Mmc. intestinalis’ among subjects
with higher frailty will need further exploration to
define whether this species may be favored merely
by factors including altered gut transit, instability of
the microbiota and increased availability of TMA or
if by itself it could trigger inflammation and
contribute to frailty. Evaluation of the immunogenic
potential of the dominant human gut Methanomas-
siliicoccales, and more particularly those with a
predicted ability to utilize TMA, is needed to
determine whether their role could be mostly
positive through TMA removal or if a more nuanced
role is being played. A better knowledge of the
factors influencing their prevalence will be of
particular interest as Methanomassiliicoccales
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representatives are unevenly distributed in human
populations and some cohorts/subjects could be
dominated by Methanomassiliicoccales that poten-
tially lack the capacity to deplete TMA
(Vanderhaeghen et al., 2015). Although Mmc. lumi-
nyensis is currently the only Methanomassiliicoc-
cales species isolated from the human gut (or even in
general) (Dridi et al., 2012b), it might not be the best
model to study the interactions of the representatives
of this archaeal order with the gut microbiome and
the host. Isolated strains of the Methanomassiliicoc-
cales predominantly associated with the human
microbiome will be very valuable to better define
the role of Methanomassiliicoccales in health and
disease.
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